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Abstract
Dent disease is a rare X-linked tubulopathy with low molecular weight proteinuria, hypercalciuria, nephrolithiasis,
nephrocalcinosis and progressive renal failure. We describe the case of a 9-year-old boy who presented with
nephrotic-range albuminuria at the age of 3 years. In the absence of a clear diagnosis, a renal biopsy was performed at
4 years, which revealed minimal change disease. Due to the presence of low molecular weight proteinuria, even in the
absence of hypercalciuria, a diagnosis of Dent disease was considered. While there were no mutations in the CLCN5 gene,
the diagnosis was confirmed by the presence of a missense mutation (p.Arg318Cys) in the OCRL gene. Conclusion: Given
the large phenotypic variability of the disease and based on our experience, we believe that children with low molecular
weight proteinuria, even without hypercalciuria, should be investigated for Dent disease.
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Background
Dent disease is a rare, X-linked disorder characterized
by low molecular weight proteinuria (LMWP), hypercal-
ciuria, and at least one of the following criteria: nephro-
lithiasis, nephrocalcinosis, hematuria, hypophosphatemia
or progressive renal failure [1]. Other features of proximal
tubulopathy can be present, such as glycosuria, amino-
aciduria and acidification defects [1, 2]. It is caused by
mutations in the CLCN5 gene (Dent-1 disease, OMIM
#300009) in ~ 60 % of cases, in the OCRL gene (Dent-2
disease, OMIM#300555) in ~15 % of cases,, while in
the remaining 25 % of cases [3, 4] other unidentified
genes are responsible for the disease. The incidence
and prevalence of Dent-1 and 2 disease are unknown.
Several recent papers have reported an atypical pheno-
type of Dent-1 disease, presenting with high range pro-
teinuria and LMWP as a unique clinical feature [5–8].
We describe a boy who presented with asymptomatic
high range proteinuria, LMWP and normocalciuria at
the age of 3 years, and who was subsequently diagnosed
with Dent-2 disease with an OCRL mutation.
Case report
At the age of 10 months, the child presented with pro-
teinuria and hematuria (urine dipstick: pH 6, S.G. 1020,
Hb 1+, Albumin 3+) following a febrile viral infection.
Renal function, C3 and C4 serum levels were all normal;
extractible nuclear antigen, antinuclear antibodies and anti
DNA antibodies were negative. Proteinuria (600–800 mg/
day) was confirmed in subsequent evaluations without
hypoalbuminemia, edema or hyperlipidemia. Kidney
ultrasound was normal. There was no family history of
kidney disease.
At the age of 4, he was referred to our hospital with
nephrotic range proteinuria (uPr/uCr mg/mg between
1.4 and 4.4), albuminuria 100–300 mg/dl and a high com-
ponent of LMWP, but without hypercalciuria (uCa/uCr
mg/mg: 0.38 normal < 0.4 for children from 3 to 5 years),
nephrocalcinosis or signs of tubular damage (tubular re-
absorption of phosphate > 82 %, absence of glycosuria and
aminoaciduria). A technetium-99 m-dimercaptosuccinate
(DMSA) scan revealed: “poor renal accumulation of radio-
nuclide 3 h after injection”. A renal biopsy was then per-
formed which showed “minor glomerular abnormalities”
typical of minimal change disease.
The child underwent regular six-monthly check-ups
during which time no clinical, laboratory or renal US
changes were observed. Albuminuria, LMWP were
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persistently elevated while values of urinary calcium
were within the normal range for age.
On the basis of some reports of patients with Dent-1
disease, whose initial clinical presentation was proteinuria
with LMWP but without hypercalciuria [5, 6], we decided
to screen our patient for CLCN5 and OCRL1 mutations.
A missense mutation (p.Arg318Cys) was identified in exon
11 of the OCRL gene. Carrier status was confirmed in the
mother.
At present, the child is nine years old and has normal
renal function (eGFR: 130 ml/min/1.73 m2), proteinuria
(uPr/uCr: 2.2) with albuminuria 201 mg/L, alpha-1 mi-
croglobulin 329 mg/L (normal 0–12 mg/L), and beta-2
microglobulin 128 mg/L (normal < 10.0 mg/L), without
hypercalciuria (uCa/uCr: 0.24 normal < 0.25) [9, 10],
nephrolithiasis or nephrocalcinosis. Mild elevations of
muscle enzymes (CPK 332 U/L, LDH 375 U/L) have been
documented, without clinical evidence of muscle weakness.
Growth, intellectual development and ophthalmic exami-
nations have all been normal up to now.
Discussion
We report a child with atypical Dent-2 disease, documented
by an OCRL mutation, who presented with isolated protein-
uria in the absence of any of the other classic criteria, par-
ticularly hypercalciuria. To date, approximately 250 families
with Dent disease have been reported [1], of whom around
40 patients had Dent-2 disease, with various OCRL muta-
tions described [1, 4].
Some studies have shown a large variability in the clin-
ical phenotype of Dent disease, so much so that we can
consider this disease to be a heterogeneous group of
proximal tubular defects called “The Dent disease complex”
[11]. A proportion of them have glomerular involvement,
as was demonstrated in six of the nine children with
Dent-1 disease presenting with asymptomatic high range
proteinuria associated with LMWP, without hypercalciuria,
and showing a focal segmental glomerulosclerosis and/or
focal global glomerulosclerosis on biopsy [5–7]. Ludwig et
al described two patients with LMWP as the only symptom
of Dent-1 disease [8]. Cramer MT et al recently re-
ported seven males with nephrotic-range proteinuria and
CLCN5 mutations, two of which showed no hypercalciuria
(Table 1). Our patient had a very similar clinical presenta-
tion to these patients, with the exception of minimal
change disease on biopsy, which, however, was performed
early in the course of the disease, perhaps before the de-
velopment of sclerotic lesions.
In this respect, it is possible that these children could
benefit from ACE inhibition, which may help protect the
kidneys from the appearance of sclerotic lesions secondary
to proteinuria. Copelovitch et al. [6] documented moder-
ate improvement in proteinuria in a Dent patient after
starting enalapril therapy, However, only a small number
of the reported patients have been treated with these drugs
[5, 7]. More studies are needed in order to draw more solid
conclusions.
Our patient has a missense mutation (p.Arg318Cys) in
exon 11 of the OCRL gene. To our knowledge, only 6
patients with the same mutation and Dent disease have
been described: two brothers by Hoopes et al. [3], one
male by Sekine T. et al [9], two brothers by Böckenhauer
Table 1 Patients with Dent-1 disease in the absence of hypercalciuria reported in the literature
Parameters Patient
1 [5]
Patient
2 [5]
Patient
3 [5]
Patient
4 [5]
Patient
5 [6]
Patient
6 [7]
Patient
7 [7]
Patient
8 [8]
Patient
9 [8]
Age (years) 9 11 14 9 9 6 6 36 15
CrCl (cc/min/1.73 m2) >90 97 105 95.5 126 79 98 135 >80 >80
S-Alb (gr/dl) 3.5-5.3 4.5 4.9 4.1 4.4 4.6 4.5 4.9 - -
U-prot (mg/day) <200 800–1000 600–1400 750–1100 1240 1321 – - - -
U-prot/U-Cr (mg/mg) <0.2 - - - - - 3.4 2.6 - -
U-β2MG (mg/l) < 10 91.2 103 120 74.4 52.7 - - >10 >10
U-β2MG (mcg/g cr) < 132 166.1 >132 >132
U-Ca/U-Cr (mg/mg) < 0.5 for 1-3y 0.15 0.14 0.13 0.12 0.07 0.18 0.10 < 0.25 < 0.25
<0.4 for 3-5 y
<0.3 for 5-7 y
< 0.25 for >7y
U-gluc absent neg neg neg neg - - - - -
TRP (%) 82-95 87.4 91.8 86.2 95.8 85 - - -
Nephrocalcinosis
by Renal US
Yes Yes No No No No Yes No No
CrCl creatinine clearance, S-Alb serum albumin, U-prot urinary protein, U-β2MG urinary beta2microglobuline, U-Ca/U-Cr urinary calcium/urinary creatinine, U-prot/U-Cr
urinary protein/urinary creatinine, U-gluc urinary glucose, TRP tubular reabsorption of phosphate, Renal US renal ultrasound
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et al. [4] and one male by Hichri et al [12] (Table 2).
Interestingly, the same mutation was identified by Hichri
et al in another patient diagnosed with Lowe syndrome.
The patients described by Hoopes and Böckenhauer had
carrier females, as did our child, while the boy described
by Sekine likely had a de novo mutation.
At diagnosis, the six patients had a mean age of
16.6 years and showed the classic hallmarks of Dent
disease with LMWP and hypercalciuria, except for
the patient described by Sekine, who lacked hypercal-
ciuria and the patient reported by Hichri, whose data
is not available. Two patients (3 and 5 in Table 2) de-
veloped a reduction in GFR during adolescence, while
a renal biopsy performed only in patient 3, demon-
strated minimal change disease, as was found in our pa-
tient. This histologic finding could lead to misdiagnosis
and inappropriate and ineffective therapies such as the
use of corticosteroids or immunosuppressive agents.
Furthermore, patients with Dent- 2 disease may share
some extra-renal symptoms with the more severe Lowe’s
syndrome, such as peripheral cataracts, mental impairment,
growth retardation and elevated creatinine kinase and lac-
tate dehydrogenase, without evidence of muscle weakness
[4, 10]. Regarding the p.Arg318Cys mutation, the patient
with Lowe syndrome reported by Hichri et al [12] pre-
sented with severe myopia, while patients with Dent disease
lack cataracts or other forms of ocular damage. An increase
of CPK and LDH enzymes was present in our patient and
in the two brothers described by Böckenhauer (patients 4
and 5 in Table 2). Some degree of mental impairment was
detected in patients 1 and 2 and short stature was noted in
patient 5. These figures confirm that, even within the same
genotype, there is a certain variability in the expression of
the severity of the disease.
The absence of hypercalciuria in our patient may be
due to his younger age and it is possible that he could
express all the hallmarks of Dent disease in the future,
but there is also the possibility that other mechanisms
could regulate and compensate for the tendency to in-
crease calcium excretion, reducing the degree of calciuria.
Therefore, the presence of hypercalciuria, typically con-
sidered pathognomonic of Dent disease, could be absent
and this should be considered as part of the variability in
the phenotype of this disease.
Conclusion
Dent-2 disease may have a variable phenotype, lacking
all the classic hallmarks, as described for some patients
with CLCN5 mutations [5–8], such that it could remain
underdiagnosed.
Based on our experience and data from the literature,
the diagnosis of Dent disease should be considered in all
patients with high range proteinuria and LMWP, even in
the absence of hypercalciuria. The CLCN5 gene, and if
negative, the OCRL1 gene should be analyzed before con-
sidering a renal biopsy in males with nephrotic range
proteinuria and no clinical signs of nephrotic syndrome.
Extra-renal symptoms (ocular involvement, mental impair-
ment, growth retardation and elevated creatinine kinase
Table 2 Patients with Dent-2 disease with the same missense mutation in exon 11 (p.Arg318Cys) as our patient
Patient 1 [3]a Patient 2 [3]a Patient 3 [9] Patient 4 [4]b Patient 5 [4]b Patient 6 [12] Our patient
Age at presentation - - 7 - - - 2
Age at diagnosis (years) 22 27 15 12 17 7 6
CrCl (cc/min/1.73 m2) - - 90 107 77 - 140
Hypercalciuria (>0.24) yes yes no yes yes - no
LMWP yes yes yes yes yes yes yes
Low TRP (%) - - - no no - no
Renal biopsy - - minor glomerular
abnormalities
- - - minimal change
disease
Elevated CPK/LDH no/no no/no yes/no yes/yes yes/yes - yes/yes
glycosuria no no no no no - no
aminoaciduria - - no no no - no
Renal tubular acidosis - - no no no - no
Nephrocalcinosis/stones no/no no/no no/no yes/no yes/no - no/no
Ocular involvement no no no no no - no
Cognitive function mild mental
retardation
mild mental
retardation
normal normal normal normal normal
Growth - - normal normal short stature - normal
CrCl creatinine clearance, LMWP low molecular weight proteinuria, TRP tubular reabsorption of phosphate, CPK creatine phosphate kinase, LDH lactate dehydrogenase
a,bbrothers
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and lactate dehydrogenase) should be looked for and could
lead to a diagnosis of Dent-2 disease.
Consent
Written informed consent was obtained from the patient
for publication of this Case report and any accompanying
images. A copy of the written consent is available for
review by the Editor-in-Chief of this journal.
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